Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Comparison of the Rhomboid Intercostal Block and Serratus Posterior Superior Intercostal Plane Block

NCT07650877 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-06-15
Last updated
2026-06-16

Condition(s) studied

Pain, PostoperativeMultimodal AnalgesiaRhomboid Intercostal BlockSerratus Posterior Superior Intercostal Plane BlockThoracic Surgery, Video-Assisted

Investigational drug(s) / intervention(s)

Rhomboid Intercostal BlockSerratus Posterior Superior Intercostal Plane Block →

Rhomboid Intercostal Block: Rhomboid intercostal block will be applied to the patients under real-time ultrasound guidance.

Serratus Posterior Superior Intercostal Plane Block: Serratus posterior superior intercostal plane block will be applied to the patients under real-time ultrasound guidance.

Study summary

Video-assisted thoracic surgery (VATS) is widely performed for the management of various thoracic pathologies and is generally associated with reduced surgical trauma compared with open thoracotomy. Nevertheless, patients may still experience considerable postoperative pain, which can adversely affect respiratory function, mobilization, and recovery. Various regional analgesic techniques have been incorporated into multimodal pain management strategies for VATS, including thoracic paravertebral block (TPVB), erector spinae plane block (ESPB), intercostal nerve block, serratus anterior plane block (SAPB), rhomboid intercostal block (RIB), and serratus posterior superior intercostal plane block (SPSIPB). Among these approaches, ultrasound-guided TPVB has traditionally been regarded as a reference regional analgesic technique. More recently, interfascial plane blocks have gained increasing attention because of their technical simplicity and favorable safety profile. RIB and SPSIPB are two novel interfascial plane blocks that may provide effective postoperative analgesia following thoracic surgery. The present study aims to compare the analgesic efficacy of RIB and SPSIPB in patients undergoing VATS and to evaluate their impact on postoperative pain outcomes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Patients undergoing elective VATS * Patients aged 18-75 years * Patients with ASA (American Society of Anesthesiologists) class I-III * Patients who have given informed consent Exclusion Criteria: * Patients allergic to local anesthetics * Patients with bleeding disorders or those undergoing anticoagulant therapy * Pregnant and breastfeeding women * Patients with impaired consciousness, inability to communicate, or mental/cognitive impairment * Patients who refuse block application * Patients with infection in the area where the block will be applied

Primary outcome measure(s)

  • Surgical Pain Scores — 24 hours after surgery
    Surgical pain will be assessed at rest and while coughing using the visual analog scale on a scale from 0mm (no pain) to 100mm (worst pain). Pain assessment will be done at 1st, 6th, 12th, and 24th hours after surgery.

Trial sites (1)

FacilityCityRegionStatus
Ankara City Hospital Çankaya Ankara Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07650877 on ClinicalTrials.gov ↗ ← All trials in Turkey